Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dianthus Therapeutics (DNTH) Other financing activities (2018 - 2024)

Dianthus Therapeutics (DNTH) has 3 years of Other financing activities data on record, last reported at $2.2 million in Q2 2024.

  • For Q2 2024, Other financing activities changed N/A year-over-year to $2.2 million; the TTM value through Mar 2025 reached $2.2 million, down 81.94%, while the annual FY2024 figure was $14.7 million, N/A changed from the prior year.
  • Other financing activities reached $2.2 million in Q2 2024 per DNTH's latest filing, down from $12.4 million in the prior quarter.
  • Across five years, Other financing activities topped out at $12.4 million in Q1 2024 and bottomed at -$436000.0 in Q3 2022.